Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2009. ,
DOI : 10.1056/NEJMoa043330
Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: First trial on rats bearing F98 gliomas, International Journal of Radiation Oncology*Biology*Physics, vol.57, issue.5, pp.1413-1426, 2003. ,
DOI : 10.1016/j.ijrobp.2003.07.007
Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.64, issue.2, pp.603-611, 2006. ,
DOI : 10.1016/j.ijrobp.2005.09.004
URL : https://hal.archives-ouvertes.fr/inserm-00388754
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects, Clinical Cancer Research, vol.11, issue.11, pp.3987-4002, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-0035
Monte Carlo dosimetry for synchrotron stereotactic radiotherapy of brain tumours, Physics in Medicine and Biology, vol.50, issue.20, pp.4841-4851, 2005. ,
DOI : 10.1088/0031-9155/50/20/007
URL : https://hal.archives-ouvertes.fr/inserm-00388924
Synchrotron stereotactic radiotherapy: dosimetry by Fricke gel and Monte Carlo simulations, Physics in Medicine and Biology, vol.49, issue.22, pp.5135-5144, 2004. ,
DOI : 10.1088/0031-9155/49/22/008
URL : https://hal.archives-ouvertes.fr/inserm-00388959
Cure of Fisher Rats Bearing Radioresistant F98 Glioma Treated with cis-Platinum and Irradiated with Monochromatic Synchrotron X-Rays, Cancer Research, vol.64, issue.7, pp.2317-2323, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-3600
URL : https://hal.archives-ouvertes.fr/inserm-00388956
Efficacy of Intracerebral Delivery of Carboplatin in Combination With Photon Irradiation for Treatment of F98 Glioma-Bearing Rats, International Journal of Radiation Oncology*Biology*Physics, vol.73, issue.2, pp.530-536, 2009. ,
DOI : 10.1016/j.ijrobp.2008.09.018
URL : https://hal.archives-ouvertes.fr/inserm-00410447
Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation Optimal photon energies for IUdR K edge radiosensitization with filtered x-ray and radioisotope sources Tumour dose enhancement using modified megavoltage photon beams and contrast media, Clinical Cancer Research Physics in Medicine and Biology Phys Med Biol, vol.13, issue.47, pp.5195-5201, 1999. ,
Synchrotron photoactivation of cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated repair pathways, Cancer Res, vol.63, pp.3221-3227, 2003. ,
Lack of cell death enhancement after irradiation with monochromatic synchrotron X rays at the K-shell edge of platinum incorporated in living SQ20B human cells as cis-diamminedichloroplatinum (II) HM: Radiotherapy enhancement with gold nanoparticles HM: The use of gold nanoparticles to enhance radiotherapy in mice, Radiat Res J Pharm Pharmacol Phys Med Biol, vol.158, issue.49, pp.763-770, 2002. ,
Motexafin-Gadolinium Taken Up In vitro by at Least 90% of Glioblastoma Cell Nuclei, Clinical Cancer Research, vol.12, issue.1, pp.206-213, 2006. ,
DOI : 10.1158/1078-0432.CCR-05-0743
Chemotherapy delivery issues in central nervous system malignancy: a reality check Intracerebral chemotherapy: chronic microinfusion of cisplatin Polymer gel dosimetry for synchrotron stereotactic radiotherapy and iodine dose-enhancement measurements RT-2 and CNS-1 gliomas Nias AH: Radiation and platinum drug interaction, Barth RF: Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), pp.1387-1407, 1985. ,
Instrumentation of the ESRF medical imaging facility, Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, vol.428, issue.2-3, pp.513-527, 1999. ,
DOI : 10.1016/S0168-9002(99)00167-9
Intracerebral delivery of 5-iodo-2 '-deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4, Journal of Synchrotron Radiation Clinical Cancer Research, vol.16, issue.11, pp.573-581, 2005. ,
A comparison of several methods of estimating the survival function when there is extreme right censoring Chronic intratumoral chemotherapy of a rat tumor with cisplatin and fluorouracil Combination of aziridinylbenzoquinone and cis-platinum with radiation therapy in the 9L rat brain tumor model, Biometrics Appl Neurophysiol Int J Radiat Oncol Biol Phys, vol.41, issue.26, pp.253-259, 1983. ,
Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats, Journal of Neurosurgery, vol.99, issue.5, pp.893-898, 2003. ,
DOI : 10.3171/jns.2003.99.5.0893
Direct delivery of medication into a brain tumor through multiple chronically implanted catheters Local chemotherapy with cisplatindepot for glioblastoma multiforme, Neurosurgery Sheleg SV J Neurooncol, vol.20, issue.60, pp.286-291, 2002. ,
The role of atomic inner shell relaxations for photon-induced DNA damage Nuclear microprobe determination of platinum quantitative distribution in rat brain tumors after cisplatin or carboplatin injection for PAT treatment of glioma Gold microspheres: a selective technique for producing biologically effective dose enhancement Cho SH: Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study, Radiat Environ Biophys Nuclear Instruments & Methods in Physics Research Section B-Beam Interactions with Materials and Atoms Int J Radiat Biol Phys Med Biol, vol.43, issue.50, pp.77-84, 2000. ,
Mammalian cells loaded with platinumcontaining molecules are sensitized to fast atomic ions Boulikas T, Vougiouka M: Cisplatin and platinum drugs at the molecular level. (Review ) Barriers to carrier mediated drug and gene delivery to brain tumors, Int J Radiat Biol Oncol Rep J Control Release, vol.84, issue.110, pp.603-611, 2003. ,